BMED12-120: Pathophysiology and Pharmacology

Description

This subject provides an introduction to the pathologic basis of disease and drug treatment, and draws together knowledge gained from prerequisite subjects into the study of the aetiology and pathogenesis of disease. Students will be introduced to concepts of cellular injury, inflammation and necrosis. The fundamentals of pharmacology including targets of drug action, absorption and metabolism of drugs and drug development will also be detailed. This provides a platform for commencing the integrated study of pathophysiology, pathology and drug treatment of various disorders, beginning with pain, inflammation and neoplasia.

Subject details

Type:	Undergraduate Subject
Code:	BMED12-120
EFTSL:	0.125
Faculty:	Faculty of Health Sciences and Medicine
Semesters offered:	May 2024 [Standard Offering]
Credit:	10
Study areas:	Health, Biomedical, and Sport Sciences
Subject fees:	Commencing in 2023: $4,050.00 Commencing in 2024: $4,260.00 Commencing in 2025: $4,460.00 Commencing in 2023: $5,400.00 Commencing in 2024: $5,730.00 Commencing in 2025: $5,990.00

Learning outcomes

Explain the role of pathology in diagnosis and management of disease
Describe the major cellular adaptive mechanisms and responses, and recognise pain and inflammation as protective responses to injury
Describe the molecular basis of carcinogenesis
Compare and contrast the different mechanisms by which drugs act on the body at a cellular and molecular level
Interpret and apply the general terminology used in pharmacology
Describe the factors which determine the absorption, distribution, metabolism and excretion of drugs
Outline the process of drug development from the identification of lead compounds through clinical trials to public release
Describe the target mechanisms of drugs used to treat pain, inflammation, neoplasia and nervous system diseases

Enrolment requirements

Requisites:	Nil
Assumed knowledge:	Assumed knowledge is the minimum level of knowledge of a subject area that students are assumed to have acquired through previous study. It is the responsibility of students to ensure they meet the assumed knowledge expectations of the subject. Students who do not possess this prior knowledge are strongly recommended against enrolling and do so at their own risk. No concessions will be made for students’ lack of prior knowledge. Assumed Prior Learning (or equivalent): BMED11-110: Human Organ Systems 1 BMED12-114: Human Organ Systems 2
Restrictions:

Requisites:

Nil

Assumed knowledge:

Assumed knowledge is the minimum level of knowledge of a subject area that students are assumed to have acquired through previous study. It is the responsibility of students to ensure they meet the assumed knowledge expectations of the subject. Students who do not possess this prior knowledge are strongly recommended against enrolling and do so at their own risk. No concessions will be made for students’ lack of prior knowledge.

Assumed Prior Learning (or equivalent):

Restrictions:

Subject outlines

Subject dates

May 2024

Standard Offering
Enrolment opens:	17/03/2024
Semester start:	13/05/2024
Subject start:	13/05/2024
Last enrolment:	26/05/2024
Teaching census:	07/06/2024
Withdraw - Financial:	08/06/2024
Withdraw - Academic:	29/06/2024

Standard Offering
Enrolment opens:	17/03/2024
Semester start:	13/05/2024
Subject start:	13/05/2024
Last enrolment:	26/05/2024
Teaching census:	07/06/2024
Withdraw - Financial:	08/06/2024
Withdraw - Academic:	29/06/2024